Serial Number | 97222990 |
Word Mark | SYNVANT |
Filing Date | Monday, January 17, 2022 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, January 22, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 25, 2023 |
Goods and Services | Biological and biotechnological chemicals and chemical preparations and formulations thereof for pharmaceutical and medical use pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; antibodies for use in disease testing; synthetic peptides for pharmaceutical purposes pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for use in oncology; biological tissue grafts; biopharmaceuticals for the treatment of cancer; protein arrays for use in recombinant DNA technology for medical and diagnostic purposes; regulatory proteins for medical diagnostic use; biological preparations for medical purposes for treating disease and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, meningitis, asthma, diabetes, multiple sclerosis, acne; chemical preparations for use in DNA analysis for diagnostic and treatment purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; none of the aforesaid goods relating to gel imaging and gel analysis applications and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes |
Goods and Services | Paper and cardboard; printed matter, namely, catalogs and brochures in the field of biotechnology; Bookbinding materials for creating hardcover books, namely, book covers, crackand-peel binding paper, reinforcement strips, peel-and-stick labels, stapler and staples; printed photographs; Plastic sheets, films and bags for wrapping and packaging; Plastic film for packaging; paper tags; paper bags for packaging; printed business cards; Bags of paper or plastics for packaging; printed vouchers |
Goods and Services | Maintaining patient medical records and files; Advertising research; Business research services; Market analysis and research services; Compilation of statistical data relating to medical research; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare |
Goods and Services | Biotechnological products and preparations for laboratory use, namely, enzymes, proteins, carbohydrates, lipids, nucleic acids, DNA, immunological re-agents, and organic intermediates being fine chemicals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne, meningitis, asthma; chemicals for industrial use; assays for research purposes; unprocessed chemical polymers; chemicals for use in biotechnological product development; cells for scientific, laboratory or medical research; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; proteins for use in recombinant DNA technology for laboratory use; chemicals being reference standards for use in science and industry; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for use in vitro scientific research; assays for research purposes(duplicate entry); diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; none of the aforesaid goods relating to gel imaging and gel analysis applications and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes |
Goods and Services | Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; pathology services for medical and medical diagnostic purposes; medical testing services |
Goods and Services | Pharmaceutical research and development; medical and scientific research services in the field of cancer treatment and diagnosis, cardiology, nephrology, endocrinology; chemical, biochemical, biological and bacteriological research and analysis; Research and development in the field of diagnostic preparations; Biomedical research services; Computer aided scientific research, testing and analysis services; in the fields of medicine and pharmaceuticals; Compiling data for research purposes in the field of medical science and medical consultancy; Scientific research and custom design of pharmaceuticals; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; research and development services in the field of antibodies, antibody technology; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; DNA analysis services for scientific research purposes; blood analysis services for scientific research purposes; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; scientific and medical laboratory services; services of a chemical and biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, and solid state characterization; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 24, 2022 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 24, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks. |
US Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 24, 2022 |
Primary Code | 016 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 24, 2022 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 24, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 24, 2022 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Syngene International Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Kanataka Bangalore IN |
Party Name | Syngene International Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Kanataka Bangalore IN |
Event Date | Event Description |
Monday, January 22, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, January 22, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, June 20, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, April 25, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, April 25, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, April 5, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, March 22, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 22, 2023 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, March 22, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, March 22, 2023 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, March 22, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, March 9, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, March 9, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, March 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, December 12, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, December 12, 2022 | NON-FINAL ACTION E-MAILED |
Monday, December 12, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, November 1, 2022 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
Tuesday, November 1, 2022 | PRIORITY ACTION E-MAILED |
Tuesday, November 1, 2022 | PRIORITY ACTION WRITTEN |
Tuesday, October 25, 2022 | ASSIGNED TO EXAMINER |
Tuesday, January 25, 2022 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Tuesday, January 25, 2022 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Monday, January 24, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, January 20, 2022 | NEW APPLICATION ENTERED |